Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with amyloidosis:
- You are 18 years old or older
- You are suspected of having, or have already been diagnosed with, amyloidosis affecting the heart, supported by test results such as heart scans, blood tests, or tissue samples
- You are already scheduled to have a specific type of full-body PET/CT scan as part of your normal care or assessment
- You are able to understand what the study involves and are willing to sign a consent form
For healthy volunteers:
- You are 18 years old or older
- You have no signs of active heart or other serious illness, confirmed by a review of your medical history, a physical check-up, and a heart tracing (ECG)
- You are able to understand what the study involves and are willing to sign a consent form
Who may not be able to join:
For patients with amyloidosis:
- You have been confirmed to have amyloidosis that does not affect the heart, or a different type of heart condition that is not amyloidosis
- You are currently pregnant or breastfeeding
- You have a medical, mental health, or personal situation that the study doctor feels would prevent you from fully taking part or completing the study (confirm with trial site)
For healthy volunteers:
- You have a history of, or currently have, a significant heart, liver, kidney, or neurological (brain/nerve) condition
- You are currently pregnant or breastfeeding
- You have any condition that the study doctor believes could increase your risk from the study procedures or affect the results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613821000597
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The safety assessment; [18F]FT8 Organ Uptake measured by Standardized Uptake Value (SUV)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.